Neocis Yomi dental surgical robot (1)
The Yomi surgical robot. [Image from Neocis]

Neocis, maker of surgical technology for robot-assisted dental implants, announced today that it raised $20 million in additional funding.

Maimi-based Neocis received investments from Mirae Asset Capital/Mirae Asset Venture Investment. They have an affiliation with the Mirae Asset Financial group and invest in growth-stage healthcare and technology businesses. NVentures, NVIDIA’s venture capital arm, also participated in the funding.

Neocis develops Yomi, an FDA-cleared dental surgical robot system. The computerized robotic navigational system. assists in the preoperative and intraoperative phases of dental implantation surgery. Yomi provides software for planning procedures and offers robotic navigational guidance for surgical instruments during procedures. The company developed its system for use in partially edentulous and fully edentulous adult patients who qualify for dental implants.

Yomi assists clinicians during all phases of implant placement. Its streamlined digital planning and haptic guidance offer accuracy, efficiency and confidence for clinicians. Its uses often include flapless procedures, a less invasive surgical approach.

To date, Neocis reports more than 40,000 implants placed with robotic assistance through Yomi.

“The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” said Alon Mozes, Neocis’ co-founder and CEO. “We’re tremendously grateful to have the backing of our newest investors, including NVentures and Mirae Asset Financial Group, as well as our existing partners. This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry.”